Search
Patexia Interest Groups

Intellectual Property > Nova Content

Music festivals, film festivals, food festivals….festivals are popular venues for entertainment and each festival strives to offer the consumer a unique... Read More »
On October 19, 2017 Hush Hush Sound Inc, Michael David, and Tyler Blake (collectively “Plaintiffs”) also known as the Electronic dance music duo... Read More »
In Bayer v. Watson, the panel throws out Bayer’s patent to its Staxyn erectile dysfunction drug as being obvious, noting that the district court focused too... Read More »
Judgments and Awards On October 3, 2017, a federal court in Miami, FL awarded TM Brands $1,500,000 pursuant to a stipulated agreement reached during trial. ... Read More »
A pair of ongoing USPTO initiatives, Patents for Humanity and Patents 4 Patients, offer incentives that certain biotechnology patent applications may be eligible... Read More »
EXECUTIVE SUMMARY: When the America Invents Act was passed in 2011, most of us saw the inter partes review process as a streamlined, relatively inexpensive procedure... Read More »
Inter-Partes Review (IPR) has become an integral part of patent defense strategy. However, our analysis of IPR institution rate shows that it has steadily been... Read More »
In Merck v. Hospira, the only precedential case decided this week, a majority of the panel affirms a determination of obviousness, noting that despite the objective... Read More »
Trade Secrets: Trade secrets protection is a timely topic. Over the past few years the relevant laws and business landscape have changed dramatically. The ... Read More »
Previous posts (e.g., here and here) have discussed trademarks that are “merely descriptive” of the goods or services.  Although the registration... Read More »
Written by Peter E. Heuser, Schwabe, Williamson & Wyatt, P.C. In Smart Systems v. Chicago Transit Authority, the Circuit affirms the dismissal of a case based ... Read More »
Written by Caleb A. Bates, Ph.D., Peter Law and Eric Furman, Ph.D. Sovereign immunity refers to the doctrine that the government cannot be sued without its... Read More »
Written by Peter E. Heuser, Schwabe, Williamson & Wyatt, P.C. The Circuit affirms the decision in Secured Mail v. Universal to dismiss an infringement case... Read More »
Written by Lauren Hockett and Vlad Teplitskiy Since 2014, the USPTO has periodically issued examination guidance, analysis examples, and other insights to... Read More »
In Amgen, Inc. v. Sanofi, Appeal no. 2017-1480 (Fed. Cir., Oct. 5, 2017) the Fed. Cir. panel reversed the district court’s finding that Amgen antibody patents... Read More »
In the first nine months of 2017, we saw a continued decline in patent litigation. District court litigation was down 15 percent to 2,921, compared to 3,418 in the... Read More »
Several new green patent complaints were filed in July and August in the areas of advanced batteries, electrolyzers for sewage treatment, LED lighting, eco-friendly... Read More »
Sitting en banc, a fractured Federal Circuit (Appeal no. 2015-1177 (Fed. Cir., Oct. 4, 2017)) released 140+ pages comprising five separate opinions (7 Judges... Read More »
Broadest Reasonable Does not Mean Broadest Possible! The USPTO applies a broadest reasonable claim interpretation (BRI) to patents and patent applications. The... Read More »
Written by Jane Xia, Brenden S. Gingrich, Ph.D., and Joseph Reisman, Ph.D. The U.S. District Court for the District of Delaware recently handed down two important ... Read More »
Menu